Navigation Links
Sanofi-aventis Announces Registration Statement for CVR Related to Genzyme Acquisition Declared Effective
Date:3/29/2011

PARIS, March 29, 2011 /PRNewswire/ -- Sanofi-aventis (EURONEXT: SAN and NYSE: SNY) announced today that the registration statement relating to the Contingent Value Rights (CVRs) offered to Genzyme shareholders as part of sanofi-aventis' agreement to acquire Genzyme has been declared effective by the U.S. Securities and Exchange Commission.

In accordance with the terms of its agreement with Genzyme, sanofi-aventis has commenced an exchange offer to acquire all of the outstanding shares of Genzyme common stock for $74.00 in cash and one CVR per share.  The CVR entitles the holder to receive additional cash payments if specified milestones related to Lemtrada™ (alemtuzumab MS) are achieved over time or a milestone related to production volumes in 2011 for Cerezyme® (imiglucerase for injection) and Fabrazyme® (agalsidase beta) is achieved. Upon closing of the exchange offer, the CVRs will be listed on the Nasdaq market under the ticker symbol "GCVRZ".

The exchange offer to acquire Genzyme is scheduled to expire at 11:59 p.m., New York City time, on April 1, 2011.  Following the consummation of the exchange offer, sanofi-aventis intends to complete the acquisition of Genzyme through a merger of a wholly-owned subsidiary of sanofi-aventis with and into Genzyme, with Genzyme becoming a wholly-owned subsidiary of sanofi-aventis.

Forward Looking Statements

Any statements made in this communication that are not statements of historical fact, including statements about Sanofi-Aventis' beliefs and expectations and statements about Sanofi-Aventis' proposed acquisition of Genzyme, are forward-looking statements and should be evaluated as such. Forward-looking statements include statements that may relate to Sanofi-Aventis' plans, objectives, strategies, goals, future events, future revenues or performance, and other informatio
'/>"/>

SOURCE sanofi-aventis
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Sanofi-aventis Enters Into Research Collaboration With Columbia University to Develop New Diabetes Treatments
2. Sanofi-aventis and Regeneron Report Top-line Results from Phase III Study with aflibercept (VEGF Trap) in Second-Line Non-Small Cell Lung Cancer
3. Sanofi-Aventis Announces Approval and Closing of BMP Sunstone Acquisition Creating a Strong Consumer Health Care Platform in China
4. Sanofi-aventis to Acquire Genzyme for $74.00 in Cash Per Share Plus Contingent Value Right
5. Sanofi-aventis and Sunnybrook Health Sciences Centre Agree to Develop Treatment for Diabetic Foot Ulcers
6. Sanofi-aventis Reports Top-line Results from Phase III Study with Iniparib (BSI-201) in Metastatic Triple-Negative Breast Cancer
7. Reportlinker Adds Sanofi-Aventis: PharmaVitae Profile
8. Sanofi-aventis Oncology Data to be Presented at San Antonio Breast Cancer Symposium
9. Sanofi-aventis Sends Letter to Genzyme Seeking Clarification on Potential Board Actions
10. Covance and sanofi-aventis Finalize Agreements for 10-year Strategic R&D Alliance
11. Sanofi-aventis to Acquire BMP Sunstone Creating a Strong Consumer Healthcare Platform in China
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/27/2015)... Feb. 27, 2015 The role of the ... but one thing hasn,t changed: face-to-face meetings are seen ... with Key Opinion Leaders. Yet at the ... valuable type of interaction, field medical teams within the ... interactions. This is just one of the challenges addressed ...
(Date:2/27/2015)... YORK , Feb. 27, 2015  Pomerantz LLP ... Pharmaceuticals, Inc. ("Vitae" or the "Company") (NASDAQ: ... Robert S. Willoughby at rswilloughby@pomlaw.com or ... Vitae and certain of its officers and/or directors have ... Act of 1934.  On February 27, ...
(Date:2/27/2015)...  Acsis Inc., the market leader for supply chain ... John DiPalo , Acsis, Chief Strategy Officer, has ... Executive 2015 Provider Pro to Know. The award ... help prepare their companies, and customers, supply chains for ... list of Provider Pros to Know is featured in ...
Breaking Medicine Technology:Improving the Management of MSL Teams to Create Value across a Diverse Set of Customers 2SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Vitae Pharmaceuticals, Inc. - VTAE 2Acsis CSO John DiPalo Named Supply & Demand Chain Executive 2015 Pro to Know 2
... immunogenicity results for seasonal vaccine program follows positive results from ... plans to initiate a study of the seasonal vaccine in ... ROCKVILLE, Md., Dec. 11 Novavax, Inc. (Nasdaq: ... Phase IIa human clinical trial of its seasonal influenza VLP ...
... 11 ,Amylin Pharmaceuticals, Inc., (Nasdaq: AMLN ... ) and Alkermes, Inc. (Nasdaq: ALKS ... Administration (FDA) recently indicated that the ongoing extension ... the basis for demonstrating,comparability between intermediate-scale clinical trial ...
Cached Medicine Technology:Novavax Announces Top Line Results of Phase IIa Clinical Trial for Its Seasonal Influenza VLP (Trivalent) Vaccine Candidate 2Novavax Announces Top Line Results of Phase IIa Clinical Trial for Its Seasonal Influenza VLP (Trivalent) Vaccine Candidate 3Novavax Announces Top Line Results of Phase IIa Clinical Trial for Its Seasonal Influenza VLP (Trivalent) Vaccine Candidate 4Novavax Announces Top Line Results of Phase IIa Clinical Trial for Its Seasonal Influenza VLP (Trivalent) Vaccine Candidate 5Novavax Announces Top Line Results of Phase IIa Clinical Trial for Its Seasonal Influenza VLP (Trivalent) Vaccine Candidate 6Plans for Exenatide Once Weekly NDA Submission by End of First Half of 2009 Reaffirmed Following FDA Feedback 2Plans for Exenatide Once Weekly NDA Submission by End of First Half of 2009 Reaffirmed Following FDA Feedback 3Plans for Exenatide Once Weekly NDA Submission by End of First Half of 2009 Reaffirmed Following FDA Feedback 4Plans for Exenatide Once Weekly NDA Submission by End of First Half of 2009 Reaffirmed Following FDA Feedback 5Plans for Exenatide Once Weekly NDA Submission by End of First Half of 2009 Reaffirmed Following FDA Feedback 6Plans for Exenatide Once Weekly NDA Submission by End of First Half of 2009 Reaffirmed Following FDA Feedback 7
(Date:2/28/2015)... 2015 The Mesothelioma Applied Research ... at the International Symposium on Malignant Mesothelioma on Monday, ... the Hyatt Regency Bethesda in Bethesda, Maryland. The following ... and commitment to the mission to cure mesothelioma. , ... be presented to Miriam Ratner. Miriam runs the Meso ...
(Date:2/28/2015)... Beach, CA (PRWEB) February 28, 2015 ... needs of Central Coast area residents, recently announced a ... System. It’s a treatment option for new and ... kick off 2015 with a bright, white smile, Dr. ... discounted price of $299, marked down from the regular ...
(Date:2/28/2015)... (PRWEB) February 28, 2015 Kaylie Corrigan, ... alcohol treatment center , and current student obtaining her ... has implemented a weekly forum in psychoeducation on substance ... in Flagstaff, AZ as part of her studies. , ... need for support and counseling at the high school ...
(Date:2/28/2015)... 2015 The noted Friedman Dental Group ... have officially relaunched their website. The new version of ... contains a new section about their team members. Potential ... full biographies of each Friedman Dental Group team member ... was designed to provide our patients with the opportunity ...
(Date:2/28/2015)... (PRWEB) February 28, 2015 Javon ... recognizes Mercy Harvard Hospital as stroke capable by the ... brought via ambulance to Mercy Harvard Hospital. , The ... to indicate their ability to treat stroke according to ... allows ambulances transporting stroke patients to bypass hospitals not ...
Breaking Medicine News(10 mins):Health News:Cancer Research Foundation Honors Award Recipients 2Health News:Cancer Research Foundation Honors Award Recipients 3Health News:Cancer Research Foundation Honors Award Recipients 4Health News:Pismo Beach Dentist Announces Special for Zoom! Teeth Whitening 2Health News:Staff at Arizona Drug Addiction Treatment Center Starts Teen Sobriety Support Group at Local High School 2Health News:Friedman Dental Group Announces Their Updated Website 2Health News:Mercy Harvard Hospital Recognized as Leader in Stroke Care - Javon Bea 2
... residues in their milk. But antibiotics are sometimes used even ... hours to produce a result and do not test for ... closed, thanks to a fully automated minilab developed by scientists ... gwk Praezisionstechnik GmbH. Even at the best of ...
... investigations, researcher says , FRIDAY, May 7 (HealthDay News) -- ... variations in human eye color. , The researchers, led by ... link eye color in 6,000 Dutch people to their genetic ... sense -- blue, green, brown -- as in previous ...
... ... laundry detergent? In the spirit of Mother’s Day and as a gift to mothers (and fathers) ... applicable for babies as they are for brands. , ... (PRWEB) May 7, 2010 -- What does naming a baby have to do with ...
... ... had a family member or friend in a hospital knows just how stressful ... circle of friends and family. With the launch of a new iPhone tool ... right from your phone, instantly. You can choose who you want to communicate ...
... ... Free Baseball Tickets and More , ... Dublin, Ohio (PRWEB) -- Dynowatt, an independent provider of electricity and green power, ... game. When you “become a fan” of Dynowatt (powered by Accent Energy) on the ...
... ... preliminary shoots for the Pink Ribbon Connection’s annual breast cancer charity calendar. The calendar ... survivors of breast cancer. , ... Indianapolis, IN (PRWEB) May 6, 2010 -- Dario Infini saw a chance to give back ...
Cached Medicine News:Health News:Minilab can quickly identify antibiotic residues in milk, before it leaves the barn 2Health News:Minilab can quickly identify antibiotic residues in milk, before it leaves the barn 3Health News:Mother's Day Special: Catchword's 10 Rules for Branding Your Baby 2Health News:Mother's Day Special: Catchword's 10 Rules for Branding Your Baby 3Health News:Mother's Day Special: Catchword's 10 Rules for Branding Your Baby 4Health News:New "howsthepatient" iPhone App Provides a Simple, Seamless Way to Send Health Updates to Friends and Family 2Health News:New "howsthepatient" iPhone App Provides a Simple, Seamless Way to Send Health Updates to Friends and Family 3Health News:New "howsthepatient" iPhone App Provides a Simple, Seamless Way to Send Health Updates to Friends and Family 4Health News:Dynowatt Offers Facebook Fans a Chance to See the Rangers and Astros Play for Texas Bragging Rights 2Health News:Dynowatt Offers Facebook Fans a Chance to See the Rangers and Astros Play for Texas Bragging Rights 3Health News:Indiana Boudoir Photographer Begins Shooting Breast Cancer Charity Calendar 2
... all those involved with healthcare decisions to ... latest evidence in their field of interest ... year as the volume of evidence increases. ... the best single source available for continually ...
... CVMstat® provides leading ... of topics involving all ... including sections on diagnosis ... arterial and venous disease. ...
... to the management of common ... a response from leading experts ... more common, and often poorly ... It is a "how-to" guide ...
The Editors and Contributors are a virtual "Who's Who" in surgery, and they have prepared an outstanding program that provides expert advice on a full range of problems. Destined to be the "gold stan...
Medicine Products: